Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1393 - 1400 of 11439 results
Rising Stars: Mintz Promotes Trio In Restructuring, M&A, PE
December 20, 2022| News
Why Cellect's Federal Circuit Case Is One To Watch
December 16, 2022| News
From the Edge - In the Boardroom: Session 7 - Down Rounds
December 16, 2022| Podcast| Viewpoint
CMS Issues Additional Flexibilities to the ACO REACH Model’s Benefit Enhancements
December 16, 2022| Blog| Viewpoint
Caremark Liability Following the SEC’s New ESG Reporting Requirements
December 16, 2022| Blog| Viewpoint
Mintz's Bob Bodian On RTO, Partner Expectations And All Those Associates
December 15, 2022| News
'Caremark' Liability Following The SEC's New ESG Reporting Requirements
December 15, 2022| News
Mintz Settlement Sparks San Diego Police Department Policy Change
December 14, 2022| Article| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.